BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells

Biochemical and Biophysical Research Communications

Volumn 316, Issue 1, 2004, Pages 100-106

  Wen, Xian Zi ^a   Miyake, Satoshi ^a,b   Akiyama, Yoshimitsu ^a   Yuasa, Yasuhito ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BMP 2; Differentiation; p21 WAF1 CIP1; Pepsinogen; Proliferation

Indexed keywords

BIOLOGICAL MARKER; PEPSINOGEN II; PROTEIN P21; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STOMACH CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; G1 PHASE; GASTRIC MUCOSA; GROWTH INHIBITORS; HUMANS; PEPSINOGEN A; RATS; RECEPTORS, GROWTH FACTOR; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 1542375452     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.016     Document Type: Article

References (36)

1. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science. 242:1988;1528-1534.
2. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1996;1580-1594.
3. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32:1992;160-167.
4. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J. Cell. Physiol. 187:2001;265-276.
5. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1994;1755-1766.
6. Lyons K.M., Pelton R.W., Hogan B.L. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development. 109:1990;4833-4844.
7. Kretzschmar M., Liu F., Hata A., Doody J., Massague J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11:1997;984-995.
8. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
9. Liu F., Hata A., Baker J.C., Doody J., Cárcamo J., Harland R.M., Massagué J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature. 381:1996;620-623.
10. Yasugi S. Role of epithelial-mesenchymal interactions in differentiation of epithelium of vertebrate digestive organs. Dev. Growth Differ. 35:1993;1-9.
11. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat. Rev. Cancer. 3:2003;592-600.
12. Narita T., Saitoh K., Kameda T., Kuroiwa A., Mizutani M., Koike C., Iba H., Yasugi S. BMPs are necessary for stomach gland formation in the chicken embryo: a study using virally induced BMP-2 and noggin expression. Development. 127:2000;981-988.
13. Dewulf N., Verschueren K., Lonnoy O., Moren A., Grimsby S., Vande Spiegle K., Miyazono K., Huylebroeck D., ten Dijke P. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology. 136:1995;2652-2663.
14. Chang H., Huylebroeck D., Verschueren K., Guo Q., Matzuk M.M., Zwijsen A. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development. 126:1999;1631-1642.
15. Jarvinen H., Franssila K.O. Familial juvenile polyposis coli: increased risk of colorectal cancer. Gut. 25:1984;792-800.
16. Howe J.R., Mitros F.A., Summers R.W. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann. Surg. Oncol. 5:1998;751-756.
17. Howe J.R., Bair J.L., Sayed M.G., Anderson M.E., Mitros F.A., Petersen G.M., Velculescu V.E., Traverso G., Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28:2001;184-187.
18. Katoh M., Terada M. Overexpression of bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. J. Gastroenterol. 31:1996;137-139.
19. Wong G.A., Tang V., El-Sabeawy F., Weiss R.H. BMP-2 inhibits proliferation of human aortic smooth muscle cells via human p21cip1/waf1. Am. J. Physiol. Endocrinol. Metab. 284:2003;972-979.
20. Ghosh-Choudhury G., Kim Y.S., Simon M., Wozney J., Harris S., Ghosh-Choudhury N., Abboud H.E. Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells. Involvement of mitogen-activated protein kinase. J. Biol. Chem. 274:1999;10897-10902.
21. Ide H., Yoshida T., Matsumoto N., Aoki K., Osada Y., Sugimura T., Terada M. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res. 57:1997;5022-5027.
22. Pouliot F., Labrie C. Role of Smad1 and Smad4 proteins in the induction of p21/WAF1/CIP1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. J. Endocrinol. 172:2002;187-198.
23. Ito M., Yasui W., Kyo E., Yokozaki H., Nakayama H., Ito H., Tahara E. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling. Cancer Res. 52:1992;295-300.
24. Yokozaki H. Molecular characteristic of eight gastric cancer cell lines established in Japan. Pathol. Int. 50:2000;767-777.
25. Pu H., Gao C., Yuasa T., Namba M., Kondo A., Inada K., Sakaguchi M. Establishment and characterization of a rat pepsin-producing gastric cell line (OUMS37). In Vitro Cell Dev. Biol. Anim. 35:1999;488-490.
26. Bai Y.Q., Akiyama Y., Nagasaki H., Yagi O.K., Kikuchi Y., Saito N., Takeshita K., Iwai T., Yuasa Y. Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines. Mol. Carcinog. 28:2000;184-188.
27. Irwin M., Marin M.C., Philips A.C., Seelan R.S., Smith D.I., Liu W., Flores E.R., Tsai K.Y., Jacks T., Vousden K.H., Kaelin W.G. Jr. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 407:2000;645-648.
28. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
29. Park K., Kim S.J., Bang Y.J., Park J.G., Kim N.K., Roberts A.B., Sporn M.B. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc. Natl. Acad. Sci. USA. 91:1994;8772-8776.
30. Renault B., Calistri D., Buonsanti G., Nanni O., Amadori D., Ranzani G.N. Microsatellite instability and mutations of p53 and TGF-beta RII genes in gastric cancer. Hum. Genet. 98:1996;601-607.
31. Vincent F., Nagashima M., Takenoshita S., Khan M.A., Gemma A., Hagiwara K., Bennett W.P. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene. 15:1997;117-122.
32. Shitara Y., Yokozaki H., Yasui W., Takenoshita S., Nagamachi Y., Tahara E. Mutation of the transforming growth factor-beta type II receptor gene in human sporadic gastric carcinomas. Int. J. Oncol. 12:1998;1061-1065.
33. Ijichi H., Ikenoue T., Kato N., Mitsuno Y., Togo G., Kato J., Kanai F., Shiratori Y., Omata M. Systematic analysis of the TGF-β-Smad signaling pathway in gastrointestinal cancer cells. Biochem. Biophys. Res. Commun. 289:2001;350-357.
34. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee J., Hannon G.J., Beach D., Lassar A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1995;1018-1021.
35. Nakashima K., Yanagisawa M., Arakawa H., Taga T. Astrocyte differentiation mediated by LIF in cooperation with BMP-2. FEBS Lett. 457:1999;43-46.
36. Monzen K., Shiojima I., Hiroi Y., Kudoh S., Oka T., Takimoto E., Hayashi D., Hosoda T., Habara-Ohkubo A., Nakaoka T., Fujita T., Yazaki Y., Komuro I. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol. Cell. Biol. 19:1999;7096-7105.